Evidence map›Paper›PMID 26973434›Full record

ArticleJournal of inflammation (London, England)2016

Mycobacterium leprae alters classical activation of human monocytes in vitro.

Dorothy Fallows, Blas Peixoto, Gilla Kaplan, Claudia Manca

Open access · goldAbstract read
In one paragraph

Article in Journal of inflammation (London, England), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 24 citations in OpenAlex.

  1. AMetabolites · 2026
    Article
  2. Host-pathogen-immune interactions in an air-liquid interface airway model.Frontiers in cellular and infection microbiology · 2026
    Article
  3. IFN-γ-Driven macrophage responses in the immunity toFrontiers in cellular and infection microbiology · 2025
    Review
  4. Review
  5. Human macrophage polarization in the response toCurrent research in microbial sciences · 2021
    Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Dorothy FallowsPublic Health Research Institute, New Jersey Medical School, Rutgers University, Newark, NJ USA.
Blas PeixotoPublic Health Research Institute, New Jersey Medical School, Rutgers University, Newark, NJ USA.
Gilla KaplanThe Bill & Melinda Gates Foundation, Seattle, WA USA.
Claudia MancaPublic Health Research Institute, New Jersey Medical School, Rutgers University, Newark, NJ USA.
Rutgers, The State University of New Jersey · USBill & Melinda Gates Foundation · US

Funding

Modulation of Human Immunity by Mycobacterium lepraeR21AI101349 · NIAID · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI MANCA, CLAUDIA M.A. · 2012 to 2013
$424k
NIAID NIH HHS R21 AI101349
6 · The paper itself

Abstract

backgroundMacrophages play a central role in the pathogenesis of leprosy, caused by Mycobacterium leprae. The polarized clinical presentations in leprosy are associated with differential immune activation. In tuberculoid leprosy, macrophages show a classical activation phenotype (M1), while macrophages in lepromatous disease display characteristics of alternative activation (M2). Bacille Calmette-Guérin (BCG) vaccination, which protects against leprosy, can promote sustained changes in monocyte response to unrelated pathogens and may preferentially direct monocytes towards an M1 protective phenotype. We previously reported that M. leprae can dampen the response of naïve human monocytes to a strong inducer of pro-inflammatory cytokines, such as BCG. Here, we investigated the ability of the pathogen to alter the direction of macrophage polarization and the impact of BCG vaccination on the monocyte response to M. leprae.

findingsWe show that in vitro exposure of monocytes from healthy donors to M. leprae interferes with subsequent M1 polarization, indicated by lower levels of M1-associated cytokine/chemokines released and reduced expression of M1 cell surface markers. Exposure to M. leprae phenolic glycolipid (PGL) 1, instead of whole bacteria, demonstrated a similar effect on M1 cytokine/chemokine release. In addition, we found that monocytes from 10-week old BCG-vaccinated infants released higher levels of the pro-inflammatory cytokines TNF-α and IL-1β in response to M. leprae compared to those from unvaccinated infants.

conclusionExposure to M. leprae has an inhibitory effect on M1 macrophage polarization, likely mediated through PGL-1. By directing monocyte/macrophages preferentially towards M1 activation, BCG vaccination may render the cells more refractory to the inhibitory effects of subsequent M. leprae infection.

Indexed as

BCG vaccinationCytokineInnate immunityLeprosyMacrophageMycobacterium lepraePolarization

Identifiers

PMID26973434
PMCPMC4788835
OpenAlexW2294862404

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.